A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people ...

A pioneering study has found that an individualized approach to breast cancer screening that assesses patients' risk, rather ...

Piqray plus Faslodex significantly improved PFS in PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced breast ...

A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people with acute myeloid leukemia overcome resistance to one of the most common ...

Researchers with UC Davis Health have launched a study they hope will help improve health outcomes of Latinas who may be genetically predisposed to breast cancer.

There has been an explosion of newer HER2-directed therapies, including monoclonal antibodies, novel antibody-drug conjugates ...

New research indicates that personalized breast cancer screening based on individual risk could improve detection while reducing unnecessary testing. A new study suggests that tailoring breast cancer ...

Nearly 1 in 4 cancers detected at a community breast imaging center were in women younger than 50. Learn the risks and how to protect yourself. A new study found that nearly 1 in 4 breast cancers ...

At the San Antonio Breast Cancer Symposium, investigators reported phase III results showing that the oral selective estrogen ...

A study of more than 45,000 women found that screening women according to their level of risk was as effective in detecting tumors as the one-size-fits-most screening currently recommended. By Roni ...

Giredestrant shows significant improvement in iDFS in patients with early-stage, HR-positive, HER2-negative breast cancer.